Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

65962

	registered interest
	date	07/07/2014
	answering body	Department for Business, Innovation and Skills
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Life Sciences: Northern Ireland
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Innovation and Skills, what work the Life Science Investment Organisation is doing to promote the life sciences sector in Northern Ireland.
	tabling member constituency	Bury South
	tabling member printed	Mr Ivan Lewis
	uin	204143
	answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>The Life Sciences Organisation (LSO) (previously the Life Sciences Investment Organisation, which now includes responsibility for UK trade promotion) works to promote the UK Life Sciences sector as a whole. LSO works closely with Invest Northern Ireland, along with the other devolved bodies and local enterprise partnerships across England, to understand the nation’s internationally competitive commercial offers in life sciences. We then actively market these strengths using our international network of investment advisors and suite of promotional materials. Where potential investors have specifically stated particular requirements, we will match these to the various regional offers and bring these out clearly in the tailored proposition materials produced for the investors.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 22/07/2014 14:48:34 answering member 4020 label Biography information for George Freeman
	tabling member	441 label Biography information for Mr Ivan Lewis

77653

	registered interest
	date	14/07/2014
	answering body	Department for Business, Innovation and Skills
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Manufacturing Industries: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Innovation and Skills, what steps his Department is taking to encourage international pharmaceutical companies to locate in the UK.
	tabling member constituency	Salisbury
	tabling member printed	John Glen
	uin	205633
	answer	answer is ministerial correction date of answer 28/08/2014 answer text <p>In December 2011, the Government launched the Strategy for UK Life Sciences which includes measures to improve the commercial, research and regulatory environment, with the aim of making the UK the location of choice for investment. Government has also taken steps to strengthen protection for intellectual property in the UK.</p><p>In 2012 a specific organisation was set up to promote life sciences to international companies: the Life Sciences Investment Organisation (now reformed as the Life Sciences Organisation (LSO), with responsibility also for UK trade promotion). LSO collects and distils information on the UK’s internationally competitive commercial offers in life sciences; these are marketed to potential investors via the UK Trade and Investment global network of investment advisors, with tailored support provided to those investors that choose the UK.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 28/08/2014 15:54:58 answering member 4020 label Biography information for George Freeman
	tabling member	4051 label Biography information for John Glen

79384

	registered interest
	date	22/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Licensing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the prevalence and efficacy of the procurement and use of off-patent drugs in the NHS.
	tabling member constituency	South Down
	tabling member printed	Ms Margaret Ritchie
	uin	206976
	answer	answer is ministerial correction date of answer 01/09/2014 answer text <p> </p><p>We have made no such assessment.</p><p> </p><p> </p><p> </p><p>There are mechanisms in place to ensure that the reimbursement prices paid by the National Health Service to dispensing contractors for generic (off-patent) medicines dispensed in primary care provide value for money for the NHS in the majority of instances.</p><p> </p><p> </p><p> </p><p>For example, Part VIII of the Drug Tariff lists the most commonly prescribed products with a reimbursement price that dispensing contractors will be paid. Setting a reimbursement price encourages contractors to seek lower prices and procure in a manner that is cost-effective for the NHS.</p><p> </p><p> </p><p> </p><p>In 2013, 83.9% of NHS prescriptions in primary care were prescribed generically.</p><p> </p><p> </p><p>Generic products in secondary care are tendered by the Department’s Commercial Medicines Unit in collaboration with the NHS through a national programme that ensures value for money by offering the NHS’ requirement to the market on a consolidated basis, whilst ensuring quality standards are maintained.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 01/09/2014 16:04:27 answering member 4020 label Biography information for George Freeman
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick